Drug Sensitivity Assay
Drug Sensitivity Assay - Related Videos
03:57
Sulforhodamine B Assay: A Sensitive Assay to Measure Drug Resistance Via Determination of Cellular Protein Content in Cancer Cells
0 Views •
2023
This video describes the high throughput colorimetric screening assay, sulforhodamine B assay, to measure drug-induced cytotoxicity in cancer cells. The assay determines the drug resistance by measuring the cell density based on the cellular protein content.
09:39
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
0 Views •
Cited by 6 •
2014
Persistent activation of inhibitory G protein-coupled receptors results in sensitization of adenylyl cyclase signaling. To identify the essential molecular pathways, nonbiased approaches are necessary; however, this strategy requires the development of a scalable cell-based cAMP sensitization assay. Herein, we describe a sensitization assay for small molecule and siRNA screening.
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
0 Views •
Cited by 4 •
2015
Here, real-time monitoring of tumor cell metabolism, combined with an in vivo chicken embryo chorio-allantoic membrane (CAM) model of metastasis, are used to evaluate novel anti-cancer targets/agents for their ability to sensitize tumor cells to DNA damaging chemotherapeutics.
09:41
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
0 Views •
Cited by 29 •
2015
We describe a high-throughput drug sensitivity assay for primary multiple myeloma cells. It consists of a reconstruction of the bone marrow microenvironment (including extracellular matrix and stroma) in multi-well plates, and a non-invasive method for longitudinal quantification of cell viability.
08:34
Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment
0 Views •
Cited by 1 •
2016
The first step in the arenavirus life cycle is attachment of viral particles to host cells. We report a quantitative (q)RT-PCR-based assay for ultrasensitive detection and quantitation of arenavirus attachment events.
FAQs
The concentration range is central because it shows whether response changes as exposure increases. Measurements across that range are assembled into a dose-response profile, allowing investigators to compare how strongly different samples react and how much drug is associated with growth inhibition, reduced viability, or microbial killing. This graded view is more informative than a single tested concentration.
Viability, growth inhibition, and microbial killing represent related but distinct response readouts. Viability focuses on whether cells remain alive, growth inhibition captures reduced expansion, and killing addresses loss of microorganisms. Selecting the readout that matches the biological system helps investigators interpret what the drug did and compare results appropriately across cancer or antimicrobial studies.
Resistance becomes apparent when a population shows weaker drug response than other tested samples across the concentration range. Investigators can examine this pattern alongside more responsive samples to identify resistant populations and characterize differences in sensitivity. These comparisons are important when assessing whether a candidate therapy may produce consistent effects or work only in particular biological samples.
Drug sensitivity assays support potency comparisons by placing candidate drugs against measurable response profiles. A drug producing stronger growth inhibition, greater viability reduction, or more microbial killing under the tested conditions may appear more potent in that comparison. These results can inform treatment choices and help guide development of therapies with more effective measured biological effects.
First, investigators expose cells or microorganisms to a series of candidate-drug concentrations. They then measure a selected response, such as viability, growth inhibition, or microbial killing, and organize the measurements into a dose-response profile. Comparing profiles across drugs or samples can reveal relative potency, differences in sensitivity, and resistant populations relevant to treatment decisions.
In antimicrobial work, the measured response helps characterize how microorganisms react to candidate treatments. In cancer research, cell responses can be compared across samples to examine treatment sensitivity. The same concentration-response framework therefore supports distinct biological systems while preserving a common goal: linking drug exposure to measurable effects in the relevant medical research context.
Results can connect a particular sample's response pattern with candidate treatment options. When samples differ in viability, growth inhibition, or killing across the same concentration range, those differences provide evidence for comparing therapies and identifying which may be more effective for that biological context. In medicine, this supports personalized treatment research by tying decisions to measured rather than assumed sensitivity.